Management post ACS in primary care
Assessment and Investigations:
- attitude and psychological state. Exercise and abilities and propensities. Dietary habits and knowledge
- smoking habits
- blood pressure
- full lipid profile (cholesterol will be lower than usual for 6 weeks post MI)
Management:
- cardiac rehabilitation
- stop smoking (record smoking status and advice)
- dietary advice with weight control if indicated
- control BP - treatment threshold is 140/90
A schemata has been suggested (1):

Medication Regimes: The following drug interventions work by independent mechanisms and their effects seem to be additive. All patients who have had an acute MI should be offered treatment with a combination of the following drugs (1):
- drug therapy
- offer all people who have had an acute MI treatment with the following drugs:
- ACE (angiotensin-converting enzyme) inhibitor
- dual antiplatelet therapy (aspirin plus a second antiplatelet agent)
- beta-blocker
- statin
- ensure that a clear management plan is available to the person who has had an MI and is also sent to the GP, including:
- details and timing of any further drug titration
- monitoring of blood pressure
- monitoring of renal function
- offer all people who have had an acute MI treatment with the following drugs:
- all people who have had an MI should be offered an assessment of bleeding risk at their follow-up appointment
- all people who have had an MI should be offered an assessment of left ventricular function
Notes:
- consider continuing a beta-blocker for 12 months after an MI for people without reduced left ventricular ejection fraction (1)
- do not offer people without left ventricular systolic dysfunction or heart failure, who have had an MI more than 12 months ago, treatment with a beta-blocker unless there is an additional clinical indication for a beta-blocker (1)
Reference:
- NICE (2020). Acute coronary syndromes. [NG185]
Related pages
- Trials of therapeutic intervention in MI
- Cholesterol measurement following myocardial infarction
- Secondary prevention of ischaemic heart disease
- Insulin therapy in type 2 diabetes post MI
- Lifestyle targets in prevention of coronary heart disease
- ACE inhibitors in myocardial infarction
- NICE guidance - antiplatelet therapy following myocardial infarction (MI)
- Beta-blockers in myocardial infarction
- Statins
- Calcium channel blockers in myocardial infarction
- Aldosterone antagonists in the management of heart failure
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page